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Abstract
Background: Nutrients, hormones and growth factors in dairy foods may stimulate growth
hormone (GH), insulin-like growth factor I (IGF-I), and raise the ratio of IGF-I to its binding protein,
IGFBP-3. We conducted pilot studies in Mongolia and Massachusetts to test the extent to which
milk intake raised somatotropic hormone concentrations in prepubertal children.
Methods: In Ulaanbaatar, we compared plasma levels before and after introducing 710 ml daily
whole milk for a month among 46 10–11 year old schoolchildren. In a randomized cross-over study
in Boston, we compared plasma hormone levels of 28 6–8 year old girls after one week of drinking
710 ml lowfat (2%) milk with their hormone levels after one week of consuming a macronutrient
substitute for milk.
Results: After a month of drinking whole milk, Mongolian children had higher mean plasma levels
of IGF-I (p < 0.0001), IGF-I/IGFBP-3 (p < 0.0001), and 75th percentile of GH levels (p = 0.005). After
a week of drinking lowfat milk, Boston girls had small and non-significant increases in IGF-1, IGF-1/
IGFBP-3 and GH.
Conclusion: Milk drinking may cause increases in somatotropic hormone levels of prepubertal
girls and boys. The finding that milk intake may raise GH levels is novel, and suggests that nutrients
or bioactive factors in milk may stimulate endogenous GH production.
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Background
Milk is a complex, bioactive substance honed by evolu-
tion to promote growth and development of the infant
mammal. Cow's milk and dairy products derived from
milk are widely consumed by human children and adults
well after the age of weaning. The established health ben-
efits of the macronutrient and micronutrient content of
milk include fewer dental caries, increased bone mineral
content, fewer fractures, and reduced risk of protein-defi-
ciency malnutrition and rickets [1-6]. However, the
impact of other bioactive substances in milk has been lit-
tle investigated. Dairy products contain bovine hormones
and growth factors that may alter the hormone and
growth factor levels of prepubertal children.
Several bovine enzymes, hormones, and growth factors
are selectively compartmentalized in milk [7,8]. Although
many hormones and growth factors are destroyed or deac-
tivated during digestion and first-pass hepatic metabo-
lism, several lines of evidence indicate that some
hormones or growth factors in milk may survive digestion
and remain bioactive in the plasma of milk-drinkers.
Rats fed lowfat (1%) cow's milk from the Japanese grocer
had higher levels of IGF-I and estrone sulfate than animals
fed a macronutrient substitute for milk [9]. Several studies
of radioactively labeled IGF-I have demonstrated its intact
oral absorption and plasma bioactivity in neonate and
adult animals, especially when the IGF-I is administered
with the protease inhibitor casein, the primary protein in
milk [10-15]. Human studies have consistently shown
that high milk consumption is associated with a 10%–
20% increase in circulating IGF-I levels among adults and
a 20%–30% increase among children [3,16-22]. Although
the proteins in milk could be responsible for the higher
IGF-I levels in milk-drinkers, dairy products raise IGF-I
levels more than do meat and other sources of dietary pro-
tein [17-21]. The ratio of IGF-I to its main binding pro-
tein, IGFBP-3, also rises with milk consumption,
indicating an increase in bioavailable IGF-I [16-18,20].
Two studies have recently reported that milk intake during
pregnancy results in higher birthweight offspring [23,24].
The rise in IGF-1 with milk consumption may increase
rates of twinning [25].
Most of the steroid hormones and growth factors pro-
duced by cows are identical to those produced by humans
[26]. If bovine hormones survive the digestive process,
most are presumably bioactive. To our knowledge, there
has been no macronutrient-controlled experimental
investigation of the impact of hormones and growth fac-
tors from cow's milk on the plasma hormone and growth
factor levels of children. We report here the results of two
short-term pilot studies conducted to justify a long-term
study of the impact of milk hormones and growth factors
on child development.
Methods
1. Mongolian Pilot Study
As children in the US consume large amounts of dairy
products, it is difficult to identify a control group with low
dairy intake for long-term study. We turned to Mongolia
as a possible site for a long-term study. Mongolia has a
pastoralist tradition, and milk is a staple of nomadic herd-
ers who live on the steppe. Lactose intolerance is virtually
unknown. However, a sharp rise in urban migration has
resulted in a large group of children whose families lack
access to familial herds. Until recently, the only milk
available in the capitol city, Ulaanbaatar, was prohibi-
tively expensive imported milk. Ulaanbaatar's children
lack access to milk. In Mongolia, we were able to add milk
to children's diets, rather than trying to subtract it from
the diets of American children. We report here the results
of a study conducted to determine the feasibility of a long-
term trial of the impact of milk consumption on child
development in Ulaanbaatar.
Participants
With the approval of the Mongolian Ministry of Educa-
tion and Ministry of Health Ethical Review Board, we con-
ducted a one-month pilot study in Ulaanbaatar from May
to June, 2005. The aim of the study was to determine
whether participating in research was acceptable to Mon-
golian parents, children, and institutions, and to test the
logistics of shipping milk and blood samples internation-
ally. A letter was sent to the families of all children in a 3rd
grade classroom in Public School #65 in Ulaanbaatar,
which included fifty 9–11 year old girls and boys. Families
were invited to an informational meeting at the school.
The Mongolian investigators (Drs. G and T) explained the
study protocol and obtained informed consent from par-
ents and assent from children to participate. Children
were eligible if they had no known allergy to milk. One
child elected not to enroll, two children responded too
late to be enrolled, and one child was withdrawn from the
study after developing symptoms of milk allergy. A total
of 22 girls and 24 boys completed the protocol.
Procedures
We performed a physical examination of each child at the
beginning and end of the month, with a Tanner Stage
evaluation at the first examination only. At baseline, chil-
dren completed a food frequency questionnaire regarding
their consumption of dairy products in the last seven days.
During the intervention month, children consumed three
8-ounce tetrapak "boxes" (710 ml) of conventional U.S.
UHT-pasteurized vitamin D fortified whole milk daily.
The producer of the milk accepts milk only from dairies
that do not use bovine somatotropin (BST). From days 4–
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10, four children who experienced digestive upset drank
varying amounts of milk (236, 472, or 710 ml) as they
grew accustomed to the milk. After day 10, all 46 children
drank the full 710 ml daily.
Hormone comparisons
At the beginning and end of the month, a morning 8 ml
blood sample was drawn into a heparinized tube. Blood
samples were immediately chilled, and transported cold
to a central laboratory, where serum was separated and
stored at -70°C. Serum levels of growth hormone, IGF-I,
and IGFBP-3 were determined in all samples. We com-
pared pre-intervention and post-intervention hormone
levels for each child.
2. Boston Girls and Milk Study
Participants
We conducted a randomized crossover milk feeding study
among prepubertal girls, comparing their hormone and
growth factor levels after a week of consuming conven-
tional lowfat (2%) milk compared with a week of con-
suming a vegetable-based macronutrient substitute for
milk. The study was conducted at the Boston Children's
Hospital General Clinical Research Center, and was
approved by the Children's Hospital Committee on Clin-
ical Investigation. Thirty-one 6–8 year old girls were
recruited from several pediatric clinics and by contacting
women who had visited the Cancer Risk and Prevention
Clinic of the Dana Farber Cancer Institute. Girls were eli-
gible for the study if their height, weight and body mass
index were between the 5th and 95th percentile for age,
they had no history of endocrine disorders or clinical
signs of pubertal initiation, and they had no allergy to
milk or the milk substitute. We obtained consent of par-
ents and assent of the girls for a screening physical and
taste-test of the milk substitute. A pediatrician (Dr. F) per-
formed a brief physical to ensure that each girl was in Tan-
ner Stage 1, and the girls tested the palatability of the milk
substitute before completing a second consent and assent
procedure to enroll in the trial. Three girls did not com-
plete the protocol, due to distaste for the milk substitute,
fear of blood draw, or inaccessible veins. We present
results for 28 girls who completed the trial. Most girls were
Caucasian; 2 were African American, 1 was Native Ameri-
can, and 6 were of Asian descent.
Procedures
The protocol was five weeks long, including two interven-
tion weeks and an intervening three-week 'wash-out'
return to normal diet. In one intervention week, girls con-
sumed 710 ml of 2% conventional cow's milk per day
(from a manufacturer that does not use milk from cows
treated with BST). In a second intervention week, the girls
drank 710 ml daily of a macronutrient substitute for milk
with the same calorie, protein, fat, carbohydrate, calcium
and vitamin D content as 2% cow's milk, concocted from
almond milk, coconut milk, and protein powder. During
these two intervention weeks, girls consumed otherwise
dairy-free diets. The order of the intervention weeks was
randomized. At the introductory visit, parents completed
a food frequency questionnaire about their daughter's
consumption of dairy products over the past year. Girls
consumed 99% of the milk and 92% of the milk substi-
tute.
Hormone comparisons
An afternoon 10 ml blood sample was drawn into a
heparinized tube at the end of each intervention week,
centrifuged, aliquotted, and stored at -70°C. We com-
pared the hormone and growth factor level of each girl at
the end of the milk week to her level at the end of the milk
substitute week.
3. Hormone and growth factor analysis for both studies
GH, IGF-I, and IGFBP-3 were assayed by enzyme-linked
immunoabsorbent assay (ELISA) with reagents from
Diagnostic Systems Laboratory (Webster, Texas). The IGF-
I values obtained by ELISA in our laboratory are highly
correlated (Pearson r = 0.97) with values obtained by radi-
oimmunoassay after acid chromatography. The average
intra-assay coefficients of variation for IGF-I, IGFBP-3,
and GH were 4.9%, 9.0%, and 8.0%, respectively. The
IGF-I assay was run in two batches, with limits of detec-
tion of 14 ng/ml and 21 ng/ml, respectively (both samples
for each child were included in the same batch). The lim-
its of detection were 2 ng/ml for the IGFBP-3 assay and 0.2
ng/ml for the GH assay. Results below the limit of detec-
tion were assigned the limit of detection for analysis.
4. Statistical analysis for both studies
We performed paired t-tests of differences in the means of
IGF-I and the IGF-I/IGFBP3 ratio; the GH distribution was
too skewed to apply a parametric test. We used unpaired
quantile regression to test differences in the 50th and 75th
percentiles of the distributions. We report the 75th percen-
tile because more than half the GH values were at or
below the limit of detection, and the 75th percentile cap-
tured variation above this "floor" limit. Paired statistical
techniques for quantile regression are not available; how-
ever, unpaired analyses are valid but would be less power-
ful than paired techniques if they existed. To display
results graphically, we estimated kernel density distribu-
tions of hormone and growth factor levels [27]. All analy-
ses were performed using SAS (version 9.1) software.
Results
Characteristics of children in the two pilot studies are pre-
sented in Table 1. Mongolian children are somewhat
smaller and leaner than their U.S. peers, with a profile
similar to that of U.S. 9–10 year olds [28]. The height,
Nutrition Journal 2007, 6:28 http://www.nutritionj.com/content/6/1/28
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weight and body mass index (BMI, kg/m2) of the Boston
girls was typical for U.S. girls age 6–8 years [28]. The Mon-
golian children consumed an average 0.6 servings of
whole milk, 0.7 servings of cheese/week, and 1.6 servings
of yoghurt in the week before the intervention. Fifteen
percent of children had no dairy intake at all, confirming
anecdotal reports of low dairy intake among Mongolian
urban children. The Boston girls typically consumed 15
glasses of predominantly lowfat or skim milk per week,
with an average 19 servings of other dairy products per
week.
Figure 1 shows the kernel density estimated distributions
of GH, IGF-I, and IGF-I/IFGBP-3 according to milk inter-
vention arm in each study. As expected, the distribution of
GH in both studies was skewed, with the median values in
both studies at or near the limit of detection. The highest
GH values were observed after milk consumption in both
studies. In Mongolia, large increases in IGF-I and IGF-I/
IGFBP-3 levels were observed between the beginning and
end of the milk intervention month. In Boston, there was
a subtle shift of the IGF-I and IGF-I/IGFBP-3 distributions
to higher levels after a week of consuming milk, compared
with a week of consuming milk substitute.
During the milk intervention month in Mongolia, girls
grew a mean 1.1 (0.2 sd) centimeters, 0.65 (0.2) kg, and
had a mean drop in BMI of -0.29 (0.06). Boys grew a
mean 1.0 (0.2) centimeters, 0.23 (0.1) kg, and had a mean
decrease in BMI of -0.26 (0.06). Consistent with the rapid
increase in height over the intervention month, we
observed large increases in serum GH, IGF-I, and IGF-I/
IGFBP-3 (Table 2). Large differences in the means, medi-
ans, and 75th percentile of these somatotropic hormones
were statistically significant, with the exception of median
GH, which was nearly doubled but was not statistically
significant. Changes in GH and growth factor levels from
the beginning to the end of the milk intervention month
were similar for girls and boys (data not shown).
Table 3 shows the results of statistical tests of the plasma
assays in the Boston trial. The mean, median, and 75th
percentiles were higher during the week in which the girls
drank milk, but these differences were neither large nor
statistically significant in these 6–8 year olds.
Discussion
In a Mongolian pilot study, levels of prepubertal GH, IGF-
I, and IGF-I/IGFBP-3 were markedly higher after one
month of drinking milk. In the smaller, shorter Boston
pilot study, which contrasted cow's milk to a macronutri-
ent control for cow's milk, levels of GH, IGF-I and IGF-I/
IGFBP3 were not elevated, although we observed a small
non-significant shift in somatotropin levels in the direc-
tion of the Mongolian findings. The rise in somatotropic
hormone and growth factor levels was larger in the Mon-
golian than in the Boston study, perhaps due to the longer
intervention, the fact that the Mongolian children con-
sumed less dairy at baseline, the use of whole versus low-
fat milk, the older age of the Mongolian participants, or
the baseline nutritional status of the Mongolian children.
We conducted the Mongolian feasibility pilot with limited
resources, and therefore did not attempt a macronutrient
control. During the intervention month, the Mongolian
children experienced rapid linear growth (the equivalent
of 12 cm/year) compared to an average height velocity of
5–6 cm/year in U.S. children age 10–11 years [29].
Although such rapid growth suggests that the children
may have been undernourished at the start of the trial, the
increase in GH is unlikely to be a refeeding effect of milk
nutrients. The classic hormonal profile in undernutrition
is low IGF-I, but stable or even elevated GH levels [30-33].
High GH during fasting may promote the tissue-sparing
switch from gluconeogenesis to lipolysis during periods
of undernutrition [30,31]. On refeeding, IGF-I levels
increase, but GH levels typically fall [31,32]. In the Mon-
golian children, the increase in GH levels after milk con-
sumption was proportionally higher than the increase in
Table 1: Mean (sd) baseline characteristics of participants in two pilot studies
Mongolian boys Mongolian girls Boston girls
n 24 22 28
Age 10.4 (0.7) 10.6 (0.6) 7.6 (0.9)
Weight (kg) 29.1 (0.7) 28.8 (1.0) 25.6 (4.6)
Height (cm) 132.5 (1.4) 130.8 (1.3) 123.9 (6.6)
BMI (kg/m2) 16.5 (0.3) 16.8 (0.3) 16.6 (2.0)
Tanner stage >1 12% (3/24) 4% (1/22) 0% (by design)
Per week:
Servings of milk 0.8 (1.3) 0.5 (1.0) 14.9 (5.8)
Servings of other dairy1 6.5 (6.0) 4.1 (4.0) 18.9 (10.3)
1. "Other dairy" for the Boston girls included cheese, ice cream, yoghurt, and cheese-containing dishes such as pizza or pasta. "Other dairy" for the 
Mongolia children consisted of cheese, yoghurt, or milk added to tea.
Nutrition Journal 2007, 6:28 http://www.nutritionj.com/content/6/1/28
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Distributions of plasma somatotropic hormones in two pilot studiesFigure 1
Distributions of plasma somatotropic hormones in two pilot studies. The Mongolia study compared concentrations 
of growth hormone (GH) (1a), insulin-like growth factor I (IGF-I) (1b), and the ratio of IGF-I to its binding protein 3 (IGF-I/
IGFBP-3) (1c) among 9–11 year old Mongolian boys and girls (n = 46) before (red line) and after (blue line) one month of drink-
ing 710 ml whole milk daily. The Boston study included 6–8 year old girls (n = 28) whose concentrations of GH (1d), IGF-I (1e), 
and the ratio of IGF-I/IGFBP-3 (1f) were measured after 1 week consuming 710 ml of lowfat milk daily (blue line) and one week 
of consuming a vegetable-based macronutrient substitute for milk (red line). a) Mongolian GH. b) Boston GH. c) Mongolian 
IGF-I. d) Boston IGF-I. e) Mongolian IGF-I/IGFBP-3. f) Boston IGF-I/IGFBP-3.
A) Mongolian Growth Hormone    B) Boston Growth Hormone 
C) Mongolian IGF-I        D) Boston IGF-I 
  
E) Mongolian IGF-I/IGFBP-3    F) Boston IGF-I/IGFBP-3 
(ng/ml) (ng/ml) 
(ng/ml) (ng/ml) 
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either IGF-I or IGF-I/IGFBP-3 levels. This finding is incon-
sistent with a malnutrition correction effect. As GH is
released in a pulsatile fashion, and we had only one GH
measurement in these pilot studies, we undoubtedly over-
estimated the variability of GH, reducing our statistical
power to detect a GH response to milk. Future studies
should measure GH more frequently to capture GH secre-
tory dynamics and better estimate GH levels.
Our studies suggest an immediate stimulatory impact of
milk on the secretion of GH and bioactive IGF-I. Other
studies suggest that the impact of milk on IGF-I levels is
maintained, and may grow over time. In China, 10 year
old girls randomized to consume whole milk had 9%
higher IGF-I levels after one year, and 20% higher levels
after two years (p < 0.05) [2]. In Britain, 12 year-old girls
randomized to drink approximately 300 ml/day of milk
had 10% higher IGF-I levels after 6 months of interven-
tion, and 17% higher levels at months 12 and 18 of inter-
vention (p = 0.02) [3]. To our knowledge, ours is the first
study to report GH response to dairy intake, which was
large and statistically significant among the Mongolian
children.
The findings here should be replicated in larger studies
with macronutrient and micronutrient control. If consist-
ent findings emerge, it would be important to identify the
specific bioactive factor in bovine milk that raises GH and
IGF-I levels. Although human and bovine GH are not
identical, bovine GH absorbed from milk might cross-
react with the human GH assay, and it is conceivable (but
as yet untested) that bovine GH might stimulate human
IGF-I production. Animal feeding experiments, using radi-
oactively labeled bovine vs. human GH, would be an
approach to answering the question of the origin of ele-
vated GH we observed in the children's serum. Alterna-
tively, another factor in bovine milk may stimulate
endogenous production of human GH, which would, in
Table 3: Comparison of hormone and growth factor levels among 6–8 year old Boston girls after 1 week milk consumption versus 1 
week macronutrient substitute for milk (n = 28).
Boston Mean 50th percentile 75th percentile
Growth Hormone (ng/ml) After substitute 0.89 ± 0.96 0.41 1.52
After milk 1.25 ± 1.67 0.21 1.62
p-value NA* 0.63 0.93
IGF-I (ng/ml) After substitute 257.26 ± 69.12 250.36 294.71
After milk 270.60 ± 89.46 250.20 308.77
p-value 0.35 0.99 0.68
IGF-I/IGFBP-3 After substitute 0.057 ± 0.01 0.057 0.064
After milk 0.059 ± 0.02 0.056 0.068
p-value 0.28 0.72 0.28
For means, p-values are from paired t-tests. For 50th and 75th percentiles, p-values are from unpaired quantile regression.
*T-test comparing mean GH is not appropriate, due to non-Normal GH distribution
Table 2: Change in 10 year-old Mongolian children's hormone and growth factor concentrations before and after one month of 
drinking 710 ml of American UHT whole milk daily.
Mongolia Mean 50th percentile 75th percentile
Growth Hormone (ng/ml) Pre 2.38 ± 3.27 1.23 2.60
Post 3.42 ± 4.07 2.14 5.28
p-value NA* 0.23 0.005
IGF-I (ng/ml) Pre 290.93 ± 93.98 270.70 346.95
Post 358.34 ± 125.62 333.56 449.29
p-value <0.0001 0.04 0.03
IGF-I/IGFBP-3 Pre 0.064 ± 0.016 0.062 0.068
Post 0.073 ± 0.019 0.072 0.082
p-value <0.0001 0.009 0.007
For means, p-values are from paired t-tests. For 50th and 75th percentiles, p-values are from unpaired quantile regression.
* T-test comparing mean GH not appropriate, due to non-Normal GH distribution.
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turn, provoke IGF-I production. Although bovine and
human IGF-I are identical, IGF-I absorbed from milk is
unlikely to stimulate human GH secretion, as GH levels
should drop in response to negative feedback from IGF-I
infusion. Future analysis should focus on identifying fac-
tors in milk that could stimulate human GH secretion,
such as growth hormone releasing hormone, ghrelin, or a
substance that stimulates ghrelin release.
Conclusion
Milk drinking may cause increases in somatotropic hor-
mone levels of prepubertal girls and boys. The finding that
milk intake may raise GH levels is novel, and suggests that
nutrients or bioactive factors in milk may stimulate
endogenous GH production.
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